Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-01 Purchase |
2020-09-03 5:39 pm |
TENAX THERAPEUTICS INC. | TENX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
86,000 | $1.433 | $123,240 | 3,975,990 (Indirect Direct) |
View |
| 2020-08-27 Purchase |
2020-08-31 7:38 pm |
TENAX THERAPEUTICS INC. | TENX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
32,000 | $1.4688 | $47,000 | 3,803,990 (Indirect Direct) |
View |
| 2020-08-27 Sale |
2020-08-31 7:33 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
165,263 | $0.11334 | $18,732 | 81,723,574 (Indirect Direct) |
View |
| 2020-08-24 Purchase |
2020-08-26 5:47 pm |
TENAX THERAPEUTICS INC. | TENX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
34,903 | $1.5099 | $52,700 | 3,739,990 (Indirect Direct) |
View |
| 2020-08-19 Purchase |
2020-08-21 5:56 pm |
TENAX THERAPEUTICS INC. | TENX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
311,481 | $1.4782 | $460,443 | 3,670,184 (Indirect Direct) |
View |
| 2020-08-18 Purchase |
2020-08-20 6:58 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
9,998 | $3.125 | $31,244 | 10,624,000 (Indirect Direct) |
View |
| 2020-07-17 Purchase |
2020-07-21 5:27 pm |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
4,500 | $3 | $13,500 | 10,604,004 (Indirect Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 5:54 pm |
Vaxart Inc. | VXRT | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director |
27,612,053 | $9.6696 | $266,997,653 | 291,046 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-08-31 7:13 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
0 | $0 | 82,054,100 (Direct) |
View |
| 2020-07-28 Other |
2020-07-30 8:04 pm |
2019-11-01 N/A |
TETRAPHASE PHARMACEUTICALS INC | TTPH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner |
10,377,161 | $0 | 1,419,507 (Direct) |
View |
Ownership |
2020-07-16 4:27 pm |
N/A N/A |
TENAX THERAPEUTICS INC. | TENX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
0 | $0 | 42,145,242 (Direct) |
View |
| 2020-06-26 Exercise |
2020-06-30 5:54 pm |
N/A 2024-09-26 |
Vaxart Inc. | VXRT | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director |
20,757,576 | $0 | 291,046 (Direct) |
View |
| 2020-06-26 Exercise |
2020-06-30 5:54 pm |
N/A N/A |
Vaxart Inc. | VXRT | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director |
16,666,667 | $0.3 | 291,046 (Direct) |
View |
| 2020-06-29 Exercise |
2020-06-30 5:54 pm |
N/A N/A |
Vaxart Inc. | VXRT | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director |
4,090,909 | $1.1 | 291,046 (Direct) |
View |